Search results
Search for "lactonization" in Full Text gives 78 result(s) in Beilstein Journal of Organic Chemistry.
Tandem catalysis of ring-closing metathesis/atom transfer radical reactions with homobimetallic ruthenium–arene complexes
- Yannick Borguet,
- Xavier Sauvage,
- Guillermo Zaragoza,
- Albert Demonceau and
- Lionel Delaude
Beilstein J. Org. Chem. 2010, 6, 1167–1173, doi:10.3762/bjoc.6.133
- complex [RuCl2(=CHPh)(SIMes)(PCy3)], CuCl, and dHbipy (SIMes is 1,3-dimesitylimidazolin-2-ylidene, dHbipy is 4,4'-di-n-heptyl-2,2'-bipyridine) was able to promote the ATRA of trichloroacetic acid onto cyclopentadiene followed by a lactonization into 3,3-dichloro-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan
- -2-one (18). These results prompted us to examine the cascade RCM/decomposition/ATRA/lactonization of substrate 16 into dichloro compound 18 with homobimetallic complex 1 under mild thermolysis conditions. Thus, the substrate and the catalyst precursor (5 mol %) were dissolved in toluene and heated
Graphical Abstract
Scheme 1: Reaction of homobimetallic ruthenium–indenylidene complex 1 with ethylene.
Scheme 2: Schematic illustration of tandem assisted catalysis with complexes 1 and 2.
Scheme 3: Tandem RCM/ATRC of 2,2,2-trichloro-N-(octa-1,7-dien-3-yl)acetamide (4) catalyzed by complex 1.
Scheme 4: Ruthenium catalyzed transformation of substrate 16.
Systematic investigations on the reduction of 4-aryl-4-oxoesters to 1-aryl-1,4-butanediols with methanolic sodium borohydride
- Subrata Kumar Chaudhuri,
- Manabendra Saha,
- Amit Saha and
- Sanjay Bhar
Beilstein J. Org. Chem. 2010, 6, 748–755, doi:10.3762/bjoc.6.94
- keto and ester moieties kept far apart for lactonization due to trans-geometry of the olefinic linkage) was treated with NaBH4 (4 equiv) in methanol. However, this reaction unexpectedly led to the exclusive formation of 2a. With a smaller amount (2 equiv) of NaBH4 in methanol, compound 1g gave 9 and 2a
- nucleophilic attack of the hydride is therefore not feasible. As a consequence, the –OH and –COO− are too far apart to interact with each other. Therefore a single bond between the carbinol carbon and carboxylic acid moiety is impossible and hence no possibility of rotation, lactonization and subsequent
- -oxoester to 1,4-diols was finally established (Scheme 11) when substrate 14 [40] (incapable of lactonization due to distal spatial disposition of the oxo- and methoxycarbonyl moieties imposed by the rigidity of the cyclopropane ring system) underwent selective reduction of the oxo-functionality only under
Graphical Abstract
Scheme 1: Facile reduction of γ-aryl-γ-ketoesters to the corresponding diols with methanolic NaBH4 at room te...
Scheme 2: Facile reduction of γ-aryl-α,β-unsaturated-γ-ketoesters to the diols with methanolic NaBH4 at room ...
Scheme 3: Facile reduction of γ-alkyl-γ-ketoester to the corresponding lactone with methanolic NaBH4 at room ...
Scheme 4: Reduction of methyl o-benzoylbenzoate with methanolic NaBH4.
Scheme 5: Reluctance of ester 8 towards reduction with methanolic NaBH4 at room temperature.
Scheme 6: Intermediacy of a lactone in the formation of diol.
Scheme 7: Diol formation from γ-aryl-α,β-unsaturated-γ-ketoester through the intermediacy of a saturated lact...
Figure 1: Mechanistic rationale for diol formation during the reduction of a γ-aryl-α,β-unsaturated-γ-ketoest...
Scheme 8: Intermediacy of γ-aryl-α,β-unsaturated-γ-hydroxyester during the reduction of γ-aryl-α,β-unsaturate...
Scheme 9: Reduction of γ-aryl-α,β-anti-dibromo-γ-ketoester with methanolic NaBH4.
Scheme 10: Intermediacy of γ-aryl-α,β-unsaturated-γ-hydroxyester during the reduction of γ-aryl-α,β-anti-dibro...
Scheme 11: Chemoselective reduction of keto group in the presence of ester moiety where structural rigidity pr...
Recent progress on the total synthesis of acetogenins from Annonaceae
- Nianguang Li,
- Zhihao Shi,
- Yuping Tang,
- Jianwei Chen and
- Xiang Li
Beilstein J. Org. Chem. 2008, 4, No. 48, doi:10.3762/bjoc.4.48
- resulting aldol product was desilylated and in situ lactonization gave 110. Removal of the MOM groups afforded longicin (101), which was identical to the natural product on the basis of the reported physical constants [49]. Total synthesis of murisolin Murisolin (111) is a mono-THF acetogenin, isolated from
Graphical Abstract
Scheme 1: Total synthesis of longifolicin by Marshall’s group.
Scheme 2: Total synthesis of corossoline by Tanaka’s group.
Scheme 3: Total synthesis of corossoline by Wu’s group.
Scheme 4: Total synthesis of pseudo-annonacin A by Hanessian’s group.
Scheme 5: Total synthesis of tonkinecin by Wu’s group.
Scheme 6: Total synthesis of gigantetrocin A by Shi’s group.
Scheme 7: Total synthesis of annonacin by Wu’s group.
Scheme 8: Total synthesis of solamin by Kitahara’s group.
Scheme 9: Total synthesis of solamin by Mioskowski’s group.
Scheme 10: Total synthesis of cis-solamin by Makabe’s group.
Scheme 11: Total synthesis of cis-solamin by Brown’s group.
Scheme 12: The formal synthesis of (+)-cis-solamin by Donohoe’s group.
Scheme 13: Total synthesis of cis-solamin by Stark’s group.
Scheme 14: Total synthesis of mosin B by Tanaka’s group.
Scheme 15: Total synthesis of longicin by Hanessian’s group.
Scheme 16: Total synthesis of murisolin and 16,19-cis-murisolin by Tanaka’s group.
Scheme 17: Synthesis of a stereoisomer library of (+)-murisolin by Curran’s group.
Scheme 18: Total synthesis of murisolin by Makabe’s group.
Scheme 19: Total synthesis of reticulatain-1 by Makabe’s group.
Scheme 20: Total synthesis of muricatetrocin C by Ley’s group.
Scheme 21: Total synthesis of (4R,12S,15S,16S,19R,20R,34S)-muricatetrocin (146) and (4R,12R,15S,16S,19R,20R,34S...
Scheme 22: Total synthesis of parviflorin by Hoye’s group.
Scheme 23: Total synthesis of parviflorin by Trost’s group.
Scheme 24: Total synthesis of trilobacin by Sinha’s group.
Scheme 25: Total synthesis of 15-epi-annonin I 181b by Scharf’s group.
Scheme 26: Total synthesis of squamocin A and squamocin D by Scharf’s group.
Scheme 27: Total synthesis of asiminocin by Marshall’s group.
Scheme 28: Total synthesis of asiminecin by Marshall’s group.
Scheme 29: Total synthesis of (+)-(30S)-bullanin by Marshall’s group.
Scheme 30: Total synthesis of uvaricin by the group of Sinha and Keinan.
Scheme 31: Formal synthesis of uvaricin by Burke’s group.
Scheme 32: Total synthesis of trilobin by Marshall’s group.
Scheme 33: Total synthesis of trilobin by the group of Sinha and Keinan.
Scheme 34: Total synthesis of asimilobin by the group of Wang and Shi.
Scheme 35: Total synthesis of squamotacin by the group of Sinha and Keinan.
Scheme 36: Total synthesis of asimicin by Marshall’s group.
Scheme 37: Total synthesis of asimicin by the group of Sinha and Keinan.
Scheme 38: Total synthesis of asimicin by Roush’s group.
Scheme 39: Total synthesis of asimicin by Marshall’s group.
Scheme 40: Total synthesis of 10-hydroxyasimicin by Ley’s group.
Scheme 41: Total synthesis of asimin by Marshall’s group.
Scheme 42: Total synthesis of bullatacin by the group of Sinha and Keinan.
Scheme 43: Total synthesis of bullatacin by Roush’s group.
Scheme 44: Total synthesis of bullatacin by Pagenkopf’s group.
Scheme 45: Total synthesis of rollidecins C and D by the group of Sinha and Keinan.
Scheme 46: Total synthesis of 30(S)-hydroxybullatacin by Marshall’s group.
Scheme 47: Total synthesis of uvarigrandin A and 5(R)-uvarigrandin A by Marshall’s group.
Scheme 48: Total synthesis of membranacin by Brown’s group.
Scheme 49: Total synthesis of membranacin by Lee’s group.
Scheme 50: Total synthesis of rolliniastatin 1 and rollimembrin by Lee’s group.
Scheme 51: Total synthesis of longimicin D by the group of Maezaki and Tanaka.
Scheme 52: Total synthesis of the structure proposed for mucoxin by Borhan’s group.
Scheme 53: Modular synthesis of adjacent bis-THF annonaceous acetogenins by Marshall’s group.
Scheme 54: Total synthesis of 4-deoxygigantecin by Tanaka’s group.
Scheme 55: Total synthesis of squamostatins D by Marshall’s group.
Scheme 56: Total synthesis of gigantecin by Crimmins’s group.
Scheme 57: Total synthesis of gigantecin by Hoye’s group.
Scheme 58: Total synthesis of cis-sylvaticin by Donohoe’s group.
Scheme 59: Total synthesis of 17(S),18(S)-goniocin by Sinha’s group.
Scheme 60: Total synthesis of goniocin and cyclogoniodenin T by the group of Sinha and Keinan.
Scheme 61: Total synthesis of jimenezin by Takahashi’s group.
Scheme 62: Total synthesis of jimenezin by Lee’s group.
Scheme 63: Total synthesis of jimenezin by Hoffmann’s group.
Scheme 64: Total synthesis of muconin by Jacobsen’s group.
Scheme 65: Total synthesis of (+)-muconin by Kitahara’s group.
Scheme 66: Total synthesis of muconin by Takahashi’s group.
Scheme 67: Total synthesis of muconin by the group of Yoshimitsu and Nagaoka.
Scheme 68: Total synthesis of mucocin by the group of Sinha and Keinan.
Scheme 69: Total synthesis of mucocin by Takahashi’s group.
Scheme 70: Total synthesis of (−)-mucocin by Koert’s group.
Scheme 71: Total synthesis of mucocin by the group of Takahashi and Nakata.
Scheme 72: Total synthesis of mucocin by Evans’s group.
Scheme 73: Total synthesis of mucocin by Mootoo’s group.
Scheme 74: Total synthesis of (−)-mucocin by Crimmins’s group.
Scheme 75: Total synthesis of pyranicin by the group of Takahashi and Nakata.
Scheme 76: Total synthesis of pyranicin by Rein’s group.
Scheme 77: Total synthesis of proposed pyragonicin by the group of Takahashi and Nakata.
Scheme 78: Total synthesis of pyragonicin by Rein’s group.
Scheme 79: Total synthesis of pyragonicin by Takahashi’s group.
Scheme 80: Total synthesis of squamostanal A by Figadère’s group.
Scheme 81: Total synthesis of diepomuricanin by Tanaka’s group.
Scheme 82: Total synthesis of (−)-muricatacin [(R,R)-373a] and its enantiomer (+)-muricatacin [(S,S)-373b] by ...
Scheme 83: Total synthesis of epi-muricatacin (+)-(S,R)-373c and (−)-(R,S)-373d by Scharf’s group.
Scheme 84: Total synthesis of (−)-muricatacin 373a and 5-epi-(−)-muricatacin 373d by Uang’s group.
Scheme 85: Total synthesis of four stereoisomers of muricatacin by Yoon’s group.
Scheme 86: Total synthesis of (+)-muricatacin by Figadère’s group.
Scheme 87: Total synthesis of (+)-epi-muricatacin and (−)-muricatacin by Couladouros’s group.
Scheme 88: Total synthesis of muricatacin by Trost’s group.
Scheme 89: Total synthesis of (−)-(4R,5R)-muricatacin by Heck and Mioskowski’s group.
Scheme 90: Total synthesis of muricatacin (−)-373a by the group of Carda and Marco.
Scheme 91: Total synthesis of (−)- and (+)-muricatacin by Popsavin’s group.
Scheme 92: Total synthesis of (−)-muricatacin by the group of Bernard and Piras.
Scheme 93: Total synthesis of (−)-muricatacin by the group of Yoshimitsu and Nagaoka.
Scheme 94: Total synthesis of (−)-muricatacin by Quinn’s group.
Scheme 95: Total synthesis of montecristin by Brückner’s group.
Scheme 96: Total synthesis of (−)-acaterin by the group of Franck and Figadère.
Scheme 97: Total synthesis of (−)-acaterin by Singh’s group.
Scheme 98: Total synthesis of (−)-acaterin by Kumar’s group.
Scheme 99: Total synthesis of rollicosin by Quinn’s group.
Scheme 100: Total synthesis of Rollicosin by Makabe’s group.
Scheme 101: Total synthesis of squamostolide by Makabe’s group.
Scheme 102: Total synthesis of tonkinelin by Makabe’s group.
